Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 912 across all filing types
Latest filing 2025-11-22 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Investor Presentation
Regulatory Filings
2025-11-22 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is a detailed investor presentation from Wanbury Limited dated November 22, 2025. It includes comprehensive information such as company profile, business streams, financial turnaround, board of directors, senior leadership, and strategic outlook. The subject line explicitly states it is an "Investors Presentation on Q2 & H1 FY26 Financial Results." The content includes slides with financial highlights, business strategy, operational updates, and leadership profiles, typical of an investor presentation. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The document is not a brief announcement or a certification but a full presentation intended for investors. Therefore, the correct classification is Investor Presentation (IP).
2025-11-22 English
Press Release on Financial Results for the quarter and half year ended 30th September, 2025.
Regulatory Filings
2025-11-18 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a press release dated November 18, 2025, announcing the financial results for the quarter and half year ended September 30, 2025 (Q2 & H1 FY26). It contains detailed financial highlights including revenue, EBITDA, PAT, and margins with year-over-year and quarter-over-quarter comparisons. The document also includes management commentary on performance and business initiatives. The length of the document (14,791 characters) and the presence of substantive financial data and analysis indicate it is a financial report rather than a brief announcement. The content matches the characteristics of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with comprehensive financial data and management discussion. It is not merely an announcement of results (ER) which typically contains only key highlights without detailed financials or management commentary. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2026
2025-11-18 English
Allotment of 15000 Equity Shares pursuant to Wanbury ESOP 2016.
Regulatory Filings
2025-11-13 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is an official notice under SEBI Listing Regulations announcing the outcome of the Board meeting held on November 13, 2025. While it mentions approval of unaudited financial results, those results themselves are not included; instead, the key actionable item is the allotment of 15,000 equity shares under the Company’s ESOP and the resulting increase in paid-up share capital. This constitutes an announcement of a new share issue / capital change. Under the provided taxonomy, such an announcement is classified as Share Issue/Capital Change (SHA).
2025-11-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.